Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Courtney T.S. Kureshi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5111079659. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2026: 2 papers

Papers 2

  1. Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2026.04.005↗
  2. CD4 T cells convert transient responses to KRAS inhibition to durable remissions in pancreatic cancer. Co-author DOI 10.1016/j.cell.2026.08.045↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Harshabad Singh · 2 shared papers, 2026 · strength 0.38
  2. Michael Lawrence Dougan · 2 shared papers, 2026 · strength 0.38
  3. Chong Zuo · 2 shared papers, 2026 · strength 0.38
  4. George Molina · 2 shared papers, 2026 · strength 0.38
  5. Thomas E. Clancy · 2 shared papers, 2026 · strength 0.38
  6. Douglas Adam Rubinson · 2 shared papers, 2026 · strength 0.38
  7. Brian Matthew Wolpin · 2 shared papers, 2026 · strength 0.38
  8. Brandon M. Huffman · 2 shared papers, 2026 · strength 0.38
  9. Joseph Douglas Mancias · 2 shared papers, 2026 · strength 0.38
  10. Jonathan Andrew Nowak · 2 shared papers, 2026 · strength 0.38
  11. Kimberly J. Perez · 2 shared papers, 2026 · strength 0.38
  12. Stephanie K. Dougan · 2 shared papers, 2026 · strength 0.38
  13. James M. Cleary · 2 shared papers, 2026 · strength 0.38
  14. Victoire Cardot‐Ruffino · 1 shared paper, 2026 · strength 0.19
  15. Lestat R. Ali · 1 shared paper, 2026 · strength 0.19
  16. Qiang Li · 1 shared paper, 2026 · strength 0.19
  17. Megan T. Hoffman · 1 shared paper, 2026 · strength 0.19
  18. Brendan D. Parent · 1 shared paper, 2026 · strength 0.19
  19. Andrew J. Aguirre · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.